Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.

dealstreetasia.com 19 hours, 43 minutes ago

Sg Biotech Startup Rwdc Industries Raises $22M To Produce Biodegradable Straws

The round was led by Vickers Venture Partners and US institutional investor Eversource Retirement Plan Master Trust. The post SG biotech startup RWDC Industries raises $22m to produce biodegradable straws appeared first on DealStreetAsia.
Read by 76% of LPs

chinamoneynetwork.com April 12, 2019

Idg Capital, Cdh Investments Lead $44M Series B Round In Chinese Biotech Start-up - China Money Network

Creative Biosciences, a Chinese biotechnology start-up focusing on colorectal cancer detection, announced on Friday the completion of a RMB300 million (US$44.64 million) series B round of financing led by Boston-born investment firm IDG Capital and Chinese private equity firm CDH Investments.
Read by 70% of LPs

chinamoneynetwork.com April 12, 2019

Idg Capital, Cdh Investments Lead $44M Series B Round In Chinese Biotech Start-up - China Money Network

Creative Biosciences, a Chinese biotechnology start-up focusing on colorectal cancer detection, announced on Friday the completion of a RMB300 million (US$44.64 million) series B round of financing led by Boston-born investment firm IDG Capital and Chinese private equity firm CDH Investments. Returning investors including Chinese private equity firm CD Capital, and two investment funds affiliated [...] IDG Capital, CDH Investments Lead $44M Series B Round In Chinese Biotech Start-Up comes originally from China Money Network. All Rights Reserved.
Read by 46% of LPs

dealstreetasia.com April 10, 2019

Sequoia Capital China Backs $16M Round For Biotech Company Cullgen

Chinese healthcare-focused investment firm HighLight Capital also participated in the funding round. The post Sequoia Capital China backs $16m round for biotech company Cullgen appeared first on DealStreetAsia.
Read by 74% of LPs

chinamoneynetwork.com March 22, 2019

Qiming Venture Partners Leads $42M New Round In Chinese Biotech Start-up - China Money Network

Abbisko Therapeutics, a Chinese biotech start-up that develops drugs for cancer treatment, announced on Friday that it has raised US$42 million in a new round of financing led by Chinese venture capital firm Qiming Venture Partners. New investors in the round including CICC Capital, a fund management affiliate of Chinese investment bank firm CICC, private [...] Qiming Venture Partners Leads $42M New Round In Chinese Biotech Start-Up comes originally from China Money Network. All Rights Reserved.
Read by 44% of LPs

chinamoneynetwork.com March 12, 2019

Chinese Clinical Stage Biotech Firm Inventisbio Closes $70M Series C Round - China Money Network

Chinese clinical stage biotechnology company InventisBio Inc. announced on Monday the closing of a US$70 million series C round of financing led by Chinese private equity firm Advantech Capital and CMB International Capital, a wholly-owned subsidiary of China Merchants Bank (CMB). Chinese investment management firm Pudong Innotek, and existing investors Lilly Asia Venture (LAV) and [...] Chinese Clinical Stage Biotech Firm InventisBio Closes $70M Series C Round comes originally from China Money Network. All Rights Reserved.
Read by 35% of LPs

vcaonline.com March 11, 2019

Clinical Stage Biotech Company Inventisbio Inc. Closes $70M USD Series C Financing

SHANGHAI, March 11, 2019-- InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in January 2019. This round of investment was co-led by Advantech Capital and CMBI, followed by Pudong Innotek. Also participating were existing investors Lilly Asia Venture (LAV) and OrbiMed Asia. "The new investment will accelerate the development of our clinical candidates into phase 2 trials and help us develop first-in-class drug candidates into clinical stage," said Dr. Yaolin Wang, InventisBio Chairman and CEO.
Read by 65% of LPs

prnewswire.com March 11, 2019

Clinical Stage Biotech Company Inventisbio Inc. Closes $70M USD Series C Financing

SHANGHAI, March 11, 2019 /PRNewswire/ -- InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in January 2019. This round of investment was co-led by Advantech Capital and CMBI, followed by Pudong Innotek. Also participating...
Read by 73% of LPs

phys.org March 08, 2019

Biotech Startup Raises $64M To Erase Cancer It's Even In The Name

San Diego startup Erasca said recently it has raised $64 million to develop cancer therapies with the ambitious goal of eventually curing the disease.
Read by 79% of LPs

bloombergquint.com February 28, 2019

Sequoia's China Rival Targets Drug Startups That Can Go Global

A top Chinese tech investor that's plowed $1 billion into healthcare companies since 2006, is training its focus on biotech startups it thinks have the best chance of taking on the world's top drugmakers.
Read by 74% of LPs